Once, food businesses wanted us hooked on their products. Now, as the side effects settle in, they are commodifying their next trick, writes Kate Demolder Back in 2012, Wall Street analyst Brian Lian took a chance meeting that changed his life. According to Forbes, Lian had been looking for the next big financial story and met with pharmaceutical executives to discuss his options. While there, he discovered an opportunity for licensing some rece…
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.